Breaking News

Balance Bar Sold to NBTY

November 26, 2012

Brynwood Partners VI L.P. has sold Balance Bar Company to NBTY, Inc., a portfolio company of The Carlyle Group. The transaction value was about $78 million, according to a report in the Wall Street Journal.

Balance Bar was founded in 1992 and acquired by Brynwood VI from Kraft Foods, Inc. in 2009. The company, which is headquartered in Valhalla, NY, is one of the leading brands in the high growth $1 billion nutrition/energy bar. The new acquisition joins NBTY's existing bar brands  MET-Rx  and Pure Protein, and the company said it plans to expand the brand's flavor variety and retail reach.

“We are delighted to announce the divestiture of Balance Bar, which was our first investment in our most recent fund, Brynwood VI,” said Hendrik J. Hartong III, chairman, Balance Bar and senior managing partner, Brynwood Partners. “We are grateful to all of the Balance Bar employees for their hard work anddedication to the business. We wish NBTY continued success with this great brand.”

“On behalf of Brynwood Partners, I would like to thank the Carlyle and NBTY teams for their efforts in completing this transaction. We have enjoyed the relationship,” said Ian B. MacTaggart, managing partner, Brynwood Partners.

Houlihan Lokey Capital, Inc. served as the investment banking advisor to Balance Bar.
  • Contract Manufacturing in the Supplement Industry

    Contract Manufacturing in the Supplement Industry

    Sean Moloughney, Editor||March 1, 2017
    With consumer health products in demand, manufacturing specialists offer considerable value.

  • Formulation Strategies for  Aging Consumers

    Formulation Strategies for Aging Consumers

    Stephen Tindal, Director, Science and Technology, Catalent Pharma Solutions||March 1, 2017
    Convenience, flavor and novel combinations of ingredients can help offer better product experiences.

  • Oral Solid Dose and the Psychology of Appearance

    Oral Solid Dose and the Psychology of Appearance

    Emilie Branch, Scientific Content Manager, That's Nice LLC / Nice Insight||March 1, 2017
    Improved drug delivery, enhanced efficacy and understanding patient needs are driving innovation in the solid dose market.